BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it is scheduled to present at the 13th Annual BIO CEO and Investor Conference on February 15, 2011 at 11:00 AM ET in the Park South room at the Waldorf Astoria in New York City.
